Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Decipher Labs Ltd

Your Vote -

Buy

83.33%

Hold

0.00%

Sell

16.67%

83.33%

6 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Decipher Labs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Decipher Labs - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

    30 Apr 2025, 5:46PM <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'> <tr> <td><b>Sr
  • Decipher Labs - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    29 Apr 2025, 1:12PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Decipher Labs has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    21 Apr 2025, 5:50PM As of March 2025, 16.43% is owned by Foreign Promoters and 83.57% by Public. <p align=justify> Top Promoter holding highest number of shares of Deciph
  • Decipher Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    18 Apr 2025, 5:44PM Compliance as per Regulation 74 (5) of SEBI (Depositories and Partcipants) Regulations, 2018 for the quarter ended 31st March, 2025
  • Decipher Labs - Integrated Filing (Financial)

    13 Feb 2025, 7:08PM Integrated filing for the quarter and nine months ended 31.12.2024
  • Decipher Labs - Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2024

    13 Feb 2025, 7:05PM Un audited Financial results for the quarter and nine months ended 31.12.2024
  • Decipher Labs - Board Meeting Outcome for Outcome Of Board Meeting For The Quarter And Nine Months Ended 31.12.2024 Under Reg

    13 Feb 2025, 7:02PM Outcome of the Board Meeting held on 13.02.2025
  • Decipher Labs - Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Qu

    8 Feb 2025, 12:17PM Decipher Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and ap

Key fundamentals

Evaluate the intrinsic value of Decipher Labs Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 8.9276 8.9043 11.5217 11.2976 11.2955
Liabilities 8.9276 8.9043 11.5217 11.2976 11.2955
Equity 10.1 10.1 10.1 10.1 10.1
Gross Profit 0.0197 -0.3682 0.3621 0.0155 0.1578
Net Profit 0.0233 -2.6175 0.3604 0.0962 0.168
Cash From Operating Activities -0.0297 -0.0765 0.5478 0.2725 -0.0103
NPM(%) 0.65 -323.14 36.46 9.85 11.8
Revenue 3.5316 0.81 0.9884 0.976 1.4235
Expenses 3.5119 1.1782 0.6263 0.9605 1.2657
ROE(%) 0.1 -12.15 1.67 0.44 0.78

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Decipher Labs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 824.20 -1.99 11.65 6.59 1321.50 1.39
Lotus Eye Hospital and Institute Ltd 80.41 -0.74 338.42 24.02 14.01 0.62
Bharat Immunological and Biologicals Corporation Ltd 23.00 -1.41 0.00 49.87 -39.50 0.00
Astec Lifesciences Ltd 681.00 -1.58 0.00 22.65 -687.11 0.00

Company Info

M/s. Combat Drugs Limited was incorporated as a Private Limited Company on 18th September, 1986. The Company was converted into a Public Limited Company on llth June, 1992. The Company was promoted by Mr. Suchit Mohan Lal who has vast experience in Marketing of Pharmaceutical Formulations and Mr. Ajay Karan who has experience in the Production as well as Marketing of pharmaceutical formulations. The Commercial Production of the company started in July, 1987 on Loan Licence basis. The company acquired a full fledged manufacturing unit located at Balanagar, Hyderabad on lease from M/s. Fairchild Laboratories Pvt. Ltd. and commenced Production from the said unit in August, 1988. In July, 1992 the Manufacturing activities of the Company were shifted to the present leased premises at 18A, Kushaiguda, Hyderabad. The Lease for the present premises is initially for a period of 3 years w.e.f June, 1992 which can be extended for a further period of 2 years with mutual consent. The total constructed area of 7200 Sft. is conforming to the requirements of a Pharmaceutical Unit and can accomodate Tablet, Capsule and Liquid Sections along with Laboratory, including facilities to manufacture Hi-tec Formulations with little modifications. Utilities like Power, water etc are already available on the Unit. 2011 - the Company have approved the scheme of arrangement between the company and its members and unsecured creditors. 2020 -Company name has changed to Decipher Labs Ltd. from Combat Drugs Ltd.

M/s. Combat Drugs Limited was incorporated as a Private Limited Company on 18th September, 1986. The Company was converted into a Public Limited Company on llth June, 1992. The Company was promoted by Mr. Suchit Mohan Lal who has vast experience in Marketing of Pharmaceutical Formulations and Mr. Ajay Karan who has experience in the Production as well as Marketing of pharmaceutical formulations. The Commercial Production of the company started in July, 1987 on Loan Licence basis. The company acquired a full fledged manufacturing unit located at Balanagar, Hyderabad on lease from M/s. Fairchild Laboratories Pvt. Ltd. and commenced Production from the said unit in August, 1988. In July, 1992 the Manufacturing activities of the Company were shifted to the present leased premises at 18A, Kushaiguda, Hyderabad. The Lease for the present premises is initially for a period of 3 years w.e.f June, 1992 which can be extended for a further period of 2 years with mutual consent. The total constructed area of 7200 Sft. is conforming to the requirements of a Pharmaceutical Unit and can accomodate Tablet, Capsule and Liquid Sections along with Laboratory, including facilities to manufacture Hi-tec Formulations with little modifications. Utilities like Power, water etc are already available on the Unit. 2011 - the Company have approved the scheme of arrangement between the company and its members and unsecured creditors. 2020 -Company name has changed to Decipher Labs Ltd. from Combat Drugs Ltd.

Read More

Parent Organisation

Decipher Labs Ltd.

Founded

17/09/1986

Managing Director

NSE Symbol

FAQ

The current price of Decipher Labs Ltd is

The 52-week high for Decipher Labs Ltd is

The market capitalization of Decipher Labs Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Decipher Labs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Decipher Labs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Decipher Labs Ltd shares.

The CEO of Decipher Labs Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT